
인젝티브 블로그
최신 소식 살펴보기

Injective’s Recap: Stepping into Asia’s Blockchain Frontier at Token2049
Token2049 stands out as the esteemed blockchain summit uniting Web3 innovators, industry pioneers, and influential executives from around the world at the iconic Singapore Marina Bay Sands. This year, the event scaled new heights with the presence of over 10,000 participants and 200 illustrious spe

Injective Unveils inEVM: A Groundbreaking Ethereum Rollup for Hyperscaling Multi VM Development
Injective today is introducing the launch of inEVM, the first-ever Ethereum Virtual Machine capable of achieving true composability across Cosmos and Solana. The inEVM network was developed in collaboration with Caldera, a L2 rollup infrastructure platform backed by Sequoia. With inEVM, Ethereum de

(The Block) Injective tests inEVM Layer 2 to support Ethereum applications
* Injective, has released the testnet of its inEVM Layer 2 rollup solution in partnership with Caldera. This allows Ethereum applications to run natively on the network. * Today’s date marks the testnet launch of inEVM, with a mainnet deployment scheduled for Q4. The Cosmos-based Layer 1 blockchai

INJ Domain Name Pre-registration Rules
Injective is launching the first ever native .inj domains with SPACE ID, with the highly anticipated pre-registration event finally approaching! During the past month, Injective ecosystem partners hosted a series of quests that reward you with exclusive access to pre-register your personalized INJ

1RPC Integrates Injective to Bring Enhanced Privacy Protection to Web3
1RPC has now integrated Injective, bringing privacy-focused data infrastructure to Web3. This integration will add an extra layer of privacy protection to transactions on Injective while also increasing data capabilities for dApps on Injective.

Injective Integrates Korea’s Leading Layer 1 Klaytn to Massively Scale Cross-Chain Interoperability
Injective has integrated Klaytn, marking a historic moment for the entire Web3 industry. This integration will allow native assets from both Klaytn and Injective to be seamlessly utilized for various cross-chain initiatives,



